Categories: Analysts

Byron Capital’s Tom Astle: Hang on to your RuggedCom

RuggedCom President and CEO Marzio Pozzouli. Byron Capital analyst Tom Astle think the $22 all-cash offer the company received on Monday from Belden Inc. may be followed by others.
Ruggedcom (TSX:RCM) is the talk of the TSX today after St. Louis-based Belden (NYSE:BDC), a manufacturer of signal transmission and networking products used in demanding environments, made a $22 all cash offer for the Vaughn, Ontario base company.

But as the the stock’s closing price on Monday, $22.69, might suggest, some think the Belden offer might not be the last.

In a note to clients this morning, Bryon Capital analyst Tom Astle says that while the offer represents a premium of 62% over Friday’s closing price of $13.61, the move could be just the first in a number of bids. Astle says those who might be interested in Ruggedcom include deep pockets such as ABB, Siemens or Schneider Electric.

_______________________________________________________________________________________________________________________

This story is brought to you by Cantech Letter sponsor BIOX (TSX:BX). The largest producer of biodiesel in Canada, BIOX’s proprietary production process has the capability to use a variety of feedstock, including recycled vegetable oils, agricultural seed oils, yellow greases and tallow. For more information CLICK HERE.

______________________________________________________________________________________________________________________

RuggedCom, as its name suggests, makes communications and networking equipment used in hostile or demanding environments. Success in the electric power and transportation markets have meant growth for the company, from $39 million in 2008, to nearly $94 million in fiscal 2011.

Astle believes that while Ruggedcom is profitable, it could be much more profitable as part of a larger entity. On Monday, he raised his target price on the company to $25 from his previous target of $21 because he thinks RuggedCom could achieve up to $1.90 a share in earnings for an acquirer. Multiplying this number by fifteen times equals $28 a share. With the downside on the stock now seemingly limited to Belden’s initial $22 offer, Astle recommends hanging on to Ruggedcom while the situation plays out.

____________________________________________________________________________________________________________________

___________________________________________________________________________________________________________________

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: rcm
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

5 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

12 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

12 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

13 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

1 day ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

1 day ago